Open AccessCase 2 – A case of secondary platinum-resistant ovarian cancer
Author(s) -
Marilena Di Napoli
Publication year - 2017
Publication title -
cancer breaking news
Language(s) - English
Resource type - Journals
ISSN - 2283-6594
DOI - 10.19156/cbn.2017.0048
Subject(s) - ovarian cancer , medicine , oncology , quality of life (healthcare) , serous fluid , chemotherapy , refractory (planetary science) , life quality , metastasis , cancer , nursing , astrobiology , physical therapy , physics
Patients with ovarian cancer relapsing during first-line treatment (refractory) or in the following few months (platinum-resistant) are a very heterogeneous group with various biological tumor behaviors. As this condition is linked to an unfavorable prognosis, the main objective of treatment is to palliate symptoms and preserve quality of life. While traditional chemotherapy may help to achieve this, new biological agents that have been introduced or are under development are expected to improve the quality of life and outcomes for patients with advanced ovarian cancer. This case report describes the clinical history of a 67-year-old woman with bilateral ovarian high grade serous papillary adenocarcinoma with lymph node and omentum metastasis.